Dermatologic care for lesbian, gay, bisexual, and transgender persons : Terminology, demographics, health disparities, and approaches to care - 11/02/19

Doi : 10.1016/j.jaad.2018.02.042

Howa Yeung, MD ^a,^⁎ , Kevin M. Luk, BS ^a, Suephy C. Chen, MD, MS ^a,^b, Brian A. Ginsberg, MD ^c, Kenneth A. Katz, MD, MSc, MSCE ^d
^a Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia
^b Division of Dermatology, Atlanta Veterans Affairs Medical Center, Decatur, Georgia
^c Department of Dermatology, Mount Sinai Hospital, New York, New York
^d Department of Dermatology, Kaiser Permanente, San Francisco, California

^∗Correspondence to: Howa Yeung, MD, Emory University School of Medicine, Department of Dermatology, 1525 Clifton Rd NE, Ste 100, Atlanta, GA 30322.Emory University School of MedicineDepartment of Dermatology1525 Clifton Rd NESte 100AtlantaGA30322

Abstract

More than 10 million lesbian, gay, bisexual, and transgender (LGBT) persons live in the United States. Improving their health is a public health priority. LGBT persons have specific health concerns and face health care disparities. Awareness of those issues and disparities can enable dermatologists to provide medically appropriate and culturally competent care to LGBT patients. This review highlights terminology important in caring for LGBT persons, LGBT demographics in the United States, health care disparities faced by LGBT persons, and approaches to caring for LGBT patients.

Le texte complet de cet article est disponible en PDF.

Key words : bisexual, dermatology, gay, health disparities, lesbian, LGBT, minority health, sexual minority, transgender

Abbreviations used : FTM, LGBT, MSM, STD, WSW

Plan

Terminology important to caring for LGBT persons

LGBT demographics in the United States

Health care disparities among LGBT persons

Approaches to caring for LGBT patients

Use inclusive and patient-preferred language

Elicit sexual history, including sexual orientation, gender identity, and sexual behaviors

Create a welcoming environment

	Supported in part by the Dermatology Foundation and the National Center for Advancing Translational Sciences of the National Institutes of Health under award numbers UL1TR002378 and KL2TR002381 (Dr Yeung). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
	Dr Yeung received honorarium from InVentiv Health. Dr Katz was a stockholder in Prevention Health Labs and Arrowhead Pharmaceuticals. All other authors had no potential conflicts of interest to disclose.
	Date of release: March 2019
	Expiration date: March 2022